- Home
- CFG vs IQV Comparison
CFG vs IQV Comparison
Compare CFG & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFG
- IQV
- Stock Information
- Founded
- CFG 1828
- IQV 1982
- Country
- CFG United States
- IQV United States
- Employees
- CFG N/A
- IQV N/A
- Industry
- CFG Major Banks
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CFG Finance
- IQV Health Care
- Exchange
- CFG Nasdaq
- IQV Nasdaq
- Market Cap
- CFG 21.3B
- IQV 24.9B
- IPO Year
- CFG 2014
- IQV 2013
- Fundamental
- Price
- CFG $38.99
- IQV $153.21
- Analyst Decision
- CFG Buy
- IQV Buy
- Analyst Count
- CFG 17
- IQV 20
- Target Price
- CFG $47.41
- IQV $230.55
- AVG Volume (30 Days)
- CFG 5.2M
- IQV 2.1M
- Earning Date
- CFG 04-16-2025
- IQV 05-06-2025
- Dividend Yield
- CFG 4.31%
- IQV N/A
- EPS Growth
- CFG 13.68
- IQV 0.26
- EPS
- CFG 3.15
- IQV 7.35
- Revenue
- CFG $7,116,000,000.00
- IQV $15,497,000,000.00
- Revenue This Year
- CFG $15.57
- IQV $4.08
- Revenue Next Year
- CFG $8.30
- IQV $5.88
- P/E Ratio
- CFG $12.36
- IQV $20.96
- Revenue Growth
- CFG N/A
- IQV 2.84
- 52 Week Low
- CFG $32.60
- IQV $135.97
- 52 Week High
- CFG $49.25
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- CFG 55.71
- IQV 47.11
- Support Level
- CFG $37.93
- IQV $143.65
- Resistance Level
- CFG $39.22
- IQV $156.31
- Average True Range (ATR)
- CFG 1.01
- IQV 5.56
- MACD
- CFG 0.47
- IQV 1.74
- Stochastic Oscillator
- CFG 93.25
- IQV 82.69
About CFG Citizens Financial Group Inc.
Citizens Financial Group is a bank holding company headquartered in Providence, Rhode Island. Its two primary business segments are consumer banking and commercial banking. Citizens offers a mix of retail and commercial products including capital markets and wealth options. The bank has over 1,100 branches in 14 states, although it is concentrated in the Northeast. It has over $220 billion of total assets. It generates maximum revenue from Consumer Banking Segment.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.